A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27(Kip1)-deficient cells

Current Biology

Volumn 9, Issue 4, 1999, Pages 163-173

  Coats, Steve ^a   Whyte, Peter ^b   Fero, Matthew L ^c   Lacy, Susan ^b   Chung, Grace ^a   Randel, Erin ^c,d   Firpo, Eduardo ^c   Roberts, James M ^c,d  

^a AMGEN INC   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c Department of Basic Science ^*  (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033602278     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80086-4     Document Type: Article

References (82)

1. Fantes PA, Nurse P: Control of the timing of cell division in fission yeast. Cell size mutants reveal a second control pathway. Exp Cell Res 1978, 115:317-329.
2. Russell P, Nurse P: Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell 1987, 49:559-567.
3. Cross FR: DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae. Mol Cell Biol 1988, 8:4675-4684.
4. Chang F, Herskowitz I: Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell 1990, 63:999-1011.
5. Peter M, Herskowitz I: Direct inhibition of the yeast cyclin-dependent kinase Cdc28-CIn by Far1. Science 1994, 265:1228-1231.
6. Tyers M, Futcher B: Far1 and Fus3 link the mating pheromone signal transduction pathway to three G1-phase Cdc28 kinase complexes. Mol Cell Biol 1993, 13:5659-5669.
7. Enoch T, Nurse P: Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication. Cell 1990, 60:665-673.
8. Poon RY, Chau MS, Yamashita K, Hunter T: The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 1997, 57:5168-5178.
9. Sidorova JM, Breeden LL: Rad53-dependent phosphorylation of swi6 and down-regulation of CLN1 and CLN2 transcription occur in response to DNA damage in Saccharomyces cerevisiae. Genes Dev 1997, 11:3032-3045.
10. Lee MG, Norbury CJ, Spurr NK, Nurse P: Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein. Nature 1988, 333:676-679.
11. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, et al.: Formation and activation of a cyclin E-Cdk2 complex during the G1 phase of the human cell cycle. Science 1992, 257:1689-1694.
12. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994, 14:2066-2076.
13. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK: A link between cyclin A expression and adhesion-dependent cell cycle progression [published erratum appears in Science 1994 Jan 28;263(5146):455]. Science 1993, 262:1572-1575.
14. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E: Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 1996, 271:499-502.
15. Zhu L, Harlow E, Dynlacht BD: p107 uses a p21cip1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 1995, 9:1740-1752.
16. Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995, 267:1022-1024.
17. Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB: Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol 1996, 16:7043-7053.
18. Guo K, Walsh K: Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem 1997, 272:791-797.
19. Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993, 259:1908-1912.
20. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571.
21. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H: Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505.
22. Connell-Crowley L, Elledge SJ, Harper JW: G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 1998, 8:65-68.
23. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134.
24. Matsushime H, Roussel MF, Ashmun RA Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991, 65:701-713.
25. Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 1996, 133:391-403.
26. Barral Y, Jentsch S, Mann C: G1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast. Genes Dev 1995, 9:399-409.
27. Gallego C, Gari E, Colomina N, Herrero E, Aldea M: The CIn3 cyclin is down-regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast. EMBO J 1997, 16:7196-7206.
28. Flick K, Chapman-Shimshoni D, Stuart D, Guaderrama M, Wittenberg C: Regulation of cell size by glucose is exerted via repression of the CLN1 promoter. Mol Cell Biol 1998, 18:2492-2501.
29. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, et al.: Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996, 12:1173-1180.
30. Ohtani K, DeGregori J, Nevins JR: Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 1995, 92:12146-12150.
31. Shulze A, Zerfass-Thome K, Berges J, Middendorp S, Jansen-Durr P, Henglein B: Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biol 1996, 16:4632-1638.
32. Polymenis M, Schmidt EV: Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev 1997, 11:2522-2531.
33. Cheng M, Sexl V, Sherr CJ, Roussel MF: Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1 ). Proc Natl Acad Sci USA 1998, 95:1091-1096.
34. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, et al.: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995, 82:621-630.
35. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, et al.: Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996, 384:470-474.
36. Sia RA, Herald HA, Lew DJ: Cdc28 tyrosine phosphorylation and the morphogenesis checkpoint in budding yeast. Mol Biol Cell 1996, 7:1657-1666.
37. Lew DJ, Reed SI: A cell cycle checkpoint monitors cell morphogenesis in budding yeast. J Cell Biol 1995, 129:739-49.
38. Furnari B, Rhind N, Russell P: Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 1997, 277:1495-1497.
39. O'Connell MJ, Raleigh JM, Verkade HM, Nurse P: Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997, 16:545-554.
40. Rhind N, Furnari B, Russell P: Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev 1997, 11:504-511.
41. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ: Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277:1497-1501.
42. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 9:1149-1163.
43. Rivard N, L'Allemain G, Bartek J, Pouyssegur J: Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem 1996, 271:18337-18341.
44. Coats S, Flanagan WM, Nourse J, Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996, 272:877-880.
45. Waldman T, Kinzler KW, Vogelstein B: p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995, 55:5187-190.
46. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
47. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-684.
48. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377:552-557.
49. Missero C, Di Cunto F, Kiyokawa H, Koff A Dotto GP: The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 1996, 10:3065-3075.
50. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, et al.: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85:733-744.
51. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, et al.: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720.
52. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, et al.: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996, 85:721-732.
53. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997, 11:973-983.
54. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, et al.: Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in beckwith-wiedemann syndrome. Nature 1997, 387:151-158.
55. Zhang P, Wong C, DePinho R, Harper JW, Elledge SJ: Cooperation between the Cdk inhibitors p27KIP1 and p57KIP2 in the control of tissue growth and development. Genes Dev 1998, 12:3162-3167.
56. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR: The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol 1996, 16:6965-6976.
57. Moberg K, Starz MA, Lees JA: E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996, 16:1436-1449.
58. Woo MS, Sanchez I, Dynlacht BD: p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol 1997, 17:3566-3579.
59. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, et al.: Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573.
60. Firpo EJ, Koff A, Solomon MJ, Roberts JM: Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 1994, 14:4889-4901.
61. Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ: Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996, 16:4327-4336.
62. Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864.
63. Millard SS, Yan JS, Nguyen H, Pagano M, Kiyokawa H, Koff A: Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem 1997, 272:7093-7098.
64. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997, 11:1464-1478.
65. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22.
66. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66.
67. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
68. Mendenhall MD: An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae. Science 1993, 259:216-219.
69. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP: Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996, 382:325-331.
70. Mulligan GJ, Wong J, Jacks T: p130 is dispensable in peripheral T lymphocytes: Evidence for functional compensation by p107 and pRB. Mol Cell Biol 1998, 18:206-220.
71. Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 1993, 7:2392-2404.
72. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677.
73. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, et al.: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997, 3:222-225.
74. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, et al.: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nat Med 1997, 3:227-230.
75. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, et al.: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 1997, 57:1259-1263.
76. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, et al.: Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 1998, 159:941-945.
77. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995, 15:2612-2624.
78. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, et al.: Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 1996, 10:1633-1644.
79. Kelly BL, Wolfe KG, Roberts JM: Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc Natl Acad Sci USA 1998, 95:2535-2540.
80. Desai D, Wessling HC, Fisher RP, Morgan DO: Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol 1995, 15:345-350.
81. Lacy S, Whyte P: Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene 1997, 14:2395-2406.
82. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991, 66:1217-1228.